Nonanomeric spiroketals in natural products: Structures, sources, and synthetic strategies

Chemical Reviews

Volumn 105, Issue 12, 2005, Pages 4406-4440

  Aho, Jatta E ^a   Pihko, Petri M ^a   Rissa, Terhi K ^a  

^a AALTO UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CATALYSIS; CRYSTAL STRUCTURE; ISOMERS; MICROORGANISMS; MOLECULAR STRUCTURE;

INSECT PHEROMONES; NATURAL PRODUCT SYNTHESIS; POLYKETIDE IONOPHORE ANTIBIOTICS; SPIROKETAL;

SYNTHESIS (CHEMICAL);

BIOLOGICAL PRODUCT; SPIRO COMPOUND;

CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; CYCLIZATION; REVIEW; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

BIOLOGICAL PRODUCTS; CRYSTALLOGRAPHY, X-RAY; CYCLIZATION; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 30744465911     PISSN: 00092665     EISSN: None     Source Type: Journal    
DOI: 10.1021/cr050559n     Document Type: Review

References (262)

1. For lucid accounts on the adventurous nature of total synthesis, see: (a) Sierra, M. A.; de la Torre, M. C. Dead Ends and Detours: Direct Ways to Successful Total Synthesis; Wiley-VCH: Weinheim, 2004.
2. (b) Nicolaou, K. C.; Snyder, S. A. Classics in Total Synthesis II: More Targets, Strategies, Methods; Wiley-VCH: Weinheim, 2003.
3. Perron, F.; Albizati, K. F. Chem. Rev. 1989, 89, 1617.
4. (a) For extensive reviews on stereoelectronic effects, see: (a) Kirby, A. J. The anomeric effect and related stereoelectronic effects at oxygen; Springer-Verlag: New York, 1983.
5. (b) Deslongchamps, P. Stereoelectronic effects in organic chemistry; Pergamon Press: Oxford, 1983.
6. (c) Thatcher, G. R. J. The Anomeric Effect and Associated Stereoelectronic Effects; ACS Symposium Series 539; American Chemical Society: Washington, DC, 1985.
7. (d) Juaristi, E.; Cuevas, G. The Anomeric Effect; CRC Press: Boca Raton, FL, 1995.
8. (a) Deslongchamps, P.; Rowan, D. D.; Pothier, N.; Sauve, T.; Saunders, J. K. Can. J. Chem. 1981, 59, 1105.
9. (b) Descotes, G.; Lissac, M.; Delmau, J.; Duplau, J. C. R. Acad. Sci. Ser. C 1968, 267, 1240.
10. (a) Deslongchamps, P.; Pothier, N. Can. J. Chem. 1987, 68, 597.
11. (b) Pothier, N.; Goldstein, S.; Deslongchamps, P. Helv. Chim. Acta 1992, 75, 604.
12. In addition, the word "contrathermodynamic", if read literally, means something that stands in opposition to the laws of thermodynamics. This is obviously not possible.
13. Cyclopropanes: (a) Liu, H.-W.; Walsh, C. T. The Chemistry of the Cyclopropyl Group; Rappoport, Z., Ed.; John Wiley & Sons Ltd.: New York, 1987.
14. (b) Wessjohann, C. A.; Brandt, W. Chem. Rev. 2003, 103, 1625.
15. (c) Epoxides: Marco-Contelles, J.; Molina, M. T.; Anjum, S. Chem. Rev. 2004, 104, 2857.
16. For reviews on the synthesis of spiroketals, see ref 2
17. and (a) Kluge, A. F. Heterocycles 1986, 24, 1699.
18. (b) Boivin, T. L. B. Tetrahedron 1987, 43, 3309.
19. (c) Jacobs, M. F.; Kitching, W. B. Curr. Org. Chem. 1998, 2, 395.
20. (d) Ley, S. V.; Baeschlin, D. K.; Dixon, D. J.; Foster, A. C.; Ince, S. J.; Priepke, H. W. M.; Reynolds, D. J. Chem. Rev. 2001, 101, 53.
21. (f) Mead, K. T.; Brewer, B. N. Curr. Org. Chem. 2003, 7, 227.
22. As an example, the spiroketal subunits of the calyculins and okadaic acid, both inhibitors of serine/threonine protein phosphatases, have been proposed to act as a β-turn mimics: (a) Gauss, C. M.; Sheppeck, J.; Chamberlin, A. R. Bioorg. Med. Chem. 1997, 5, 1739. As an example, the spiroketal subunits of the calyculins and okadaic acid, both inhibitors of serine/threonine protein phosphatases, have been proposed to act as a β-turn mimics
23. (b) Lindvall, M. K.; Pihko, P. M.; Koskinen, A. M. P. J. Biol. Chem. 1997, 272, 23312.
24. For discussions, see: Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of Organic Compounds; John Wiley & Sons Ltd.: New York, 1994; p 758.
25. (a) Francke, W.; Heeman, V.; Gerken, B.; Renwick, J. A. A.; Vite, J. P. Naturwissenschaften 1977, 64, 590.
26. (b) Francke, W.; Hindorf, G.; Reith, W. Angew. Chem., Int. Ed. Engl. 1978, 17, 862.
27. (c) Francke, W.; Reith, W. Liebigs Ann. Chem. 1979, 1.
28. (d) Francke, W.; Hindorf, G.; Reith, W. Naturwissenschaften 1979, 66, 618.
29. (e) Francke, W.; Reith, W.; Bergström, G.; Tengö, J. Naturwissenschaften 1980, 67, 149.
30. (f) Baker, R.; Herbert, R.; Howse, P. E.; Jones, O. T.; Francke, W.; Reith, W. J. Chem. Soc., Chem. Commun. 1980, 52.
31. (g) Francke, W.; Reith, W.; Bergström, G.; Tengö, J. Z. Naturforsch. 1981, 36, 928.
32. (h) Baker, R.; Herbert, R. H.; Parton, A. H. J. Chem. Soc., Chem. Commun. 1982, 601.
33. Francke, W.; Reith, W.; Sinnwell, V. Chem. Ber. 1980, 113, 2686.
34. Koźluk, T.; Cottier, L.; Descotes, G. Tetrahedron 1981, 37, 1875.
35. Westley, J. W. Polyether Antibiotics; Marcel Dekker: New York, 1982.
36. (a) For an excellent introduction to the structures of the dianemycin class and for the structure of endusamycin, see: Oscarson, J. R.; Bordner, J.; Celmer, W. D.; Cullen, W. P.; Huang, L. H.; Maeda, H.; Moshier, P. M.; Nishiyama, S.; Presseau, L.; Shibakawa, R.; Tone, J. J. Antibiot. 1989, 42, 37.
37. For the isolation and characterization of other members of the dianemycin class, see: (b) Dianemycin: Hamill, R. L.; Hoehn, M. M.; Pittenger, G. E.; Chamberlin, J.; Gorman, M. J. Antibiot. 1969, 22, 161.
38. (c) Leuseramycin: Mizutani, T.; Yamagishi, M.; Hara, H.; Kawashima, A.; Ômura, S.; Ôzeki, M.; Mizoue, K.; Seto, H.; Ôtake, N. J. Antibiot. 1980, 33, 137.
39. (d) Lenoremycin (A-130A, Ro 21-6150); Blount, J. F.; Evans, R. H.; Liu, C.-M.; Hermann, T.; Westley, J. W. J. Chem. Soc., Chem. Commun. 1975, 853.
40. For the origin of the name lenoremycin, see (e) Anteunis, M. J. O.; Rodios, N. A.; Verhegge, G. Bull. Soc. Chim. Belg. 1977, 86, 609.
41. (f) Moyukamycin: Nakayama, H.; Seto, H.; Ôtake, N.; Yamagishi, M.; Kawashima, A.; Mizutani, T.; Ômura, S. J. Antibiot. 1985, 38, 1433.
42. (g) X-14934A (CP-47,224): Celmer, W. D.; Moppett, C. E.; Cullen, W. P.; Oscarson, J. R.; Huang, L. H.; Shibakawa, R.; Tone, J. U.S. Patent 4,150,152, 1979.
43. (h) A-130B and A-130C: Tsuji, N.; Terui, K.; Nagashima, K.; Tori, K.; Johnson, L. F. J. Antibiot. 1980, 33, 94.
44. (i) CP-53,607 (X-14931A): Westley, J. W.; Liu, C.; Sello, L. H.; Troupe, N.; Blount, J. F.; Chiu, A.-M.; Todaro, L. J.; Miller, P. A:, Liu, M. J. Antibiot. 1984, 37, 813.
45. (j) CP-80,219: Dirlam, J. P.; Presseau-Linabury, L.; Koss, D. A. J. Antibiot. 1990, 43, 727.
46. (k) TM-531B and TM-531C: Mizutani, T.; Yamagishi, M.; Mizoue, K.; Kawashima, A.; Ômura, S.; Ôzeki, M.; Seto, H.; Ôtake, N. J. Antibiot. 1981, 34, 1369.
47. Hauske, J. R.; Kostek, G. J. Org. Chem. 1989, 54, 3500.
48. Koyama, H.; Utsumi-Oda, K. J. Chem. Soc., Perkin. Trans. 2 1977, 1531.
49. (a) Blunt, J. W.; Copp, B. R; Munro, M. H. G.; Northcote, P. T.; Prinsep, M. R. Nat. Prod. Rep. 2005, 22, 15.
50. (b) Yasumoto, T.; Murata, M. Chem. Rev. 1993, 93, 1897.
51. For reviews on ciguatoxin and related marine toxins, see: (a) Yasumoto, T.; Murata, M. Chem. Rev. 1993, 93, 1897.
52. (b) Yasumoto, T. Chem. Rec. 2001, 1, 228.
53. (a) Bidard, J.-N.; Vijverberg, H. P. M.; Frelin, C.; Chungue, E.; Legrand, A. M.; Bagnis, R.; Lazdunski, M. J. Biol. Chem. 1984, 259, 8353.
54. (b) Lombet, A.; Bidard, J.-N.; Lazdunski, M. FEBS Lett. 1987, 219, 355.
55. (c) Dechraoui, M.-Y.; Naar, J.; Pauillac, S.; Legrand, A.-M. Toxicon 1999, 37, 125.
56. (d) Anger, T.; Madge, D. J.; Mulla, M.; Riddal, D. J. Med. Chem. 2001, 44, 115.
57. (a) Murata, M.; Legrand, A.-M.; Ishibashi, Y.; Yasumoto, T. J. Am. Chem. Soc. 1989, 111, 8929.
58. (b) Satake, M.; Murata, M.; Yasumoto, T. Tetrahedron Lett. 1993, 34, 1975.
59. (c) Satake, M.; Ishibashi, Y.; Legrand, A.-M.; Yasumoto, T. Biosci. Biotechnol. Biochem. 1997, 60, 2103.
60. (d) Yasumoto, T.; Igarashi, T.; Legrand, A.-M.; Cruchet, P.; Chinain, M.; Fujita, T.; Naoki, H. J. Am. Chem. Soc. 2000, 122, 4988.
61. For leading references, see: (a) Inoue, M.; Uehara, H.; Maruyama, M.; Hirama, M. Org. Lett. 2002, 4, 4551.
62. (b) Inoue, M.; Hirama, M. Synlett 2004, 57.
63. Oishi, T.; Shoji, M.; Kumahara, N.; Hirama, M. Chem. Lett. 1997, 845.
64. Baba, T.; Huang, G.; Isobe, M. Tetrahedron 2003, 59, 6851.
65. Yasumoto, T.; Murata, M.; Oshima, Y.; Sano, M.; Matsumoto, G. K.; Clardy, J. Tetrahedron 1985, 41, 1019.
66. (a) Sasaki, K.; Wright, J. L. C.; Yasumoto, T. J. Org. Chem. 1998, 63, 2475.
67. (b) Daiguji, M.; Satake, M.; James, K. J.; Bishop, A.; Mackenzie, L.; Naoki, H.; Yasumoto, T. Chem. Lett. 1998, 7, 653.
68. (c) Suzuki, T.; Beuzenberg, V.; Mackenzie, K.; Quilliam, M. A. J. Chromatogr. A 2003, 992, 141.
69. In addition, two PTX-related seco acids have been isolated, see: (d) Daiguji, M.; Satake, M.; James, K. J.; Bishop, A.; Mackenzie, L.; Naoki, H.; Yasumoto, T. Chem. Lett. 1998, 7, 653.
70. For the total synthesis of PTX4, see: (a) Evans, D. A.; Rajapakse, H. A.; Stenkamp, D. Angew. Chem., Int. Ed. 2002, 41, 4569.
71. (b) Evans, D. A.; Rajapakse, H. A.; Chiu, A.; Stenkamp, D. Angew. Chem., Int. Ed. 2002, 41, 4573.
72. For synthetic efforts toward the pectenotoxins, see: (c) Amano, S.; Fujiwara, K.; Murai, A. Synlett 1997, 1300.
73. (d) Awakura, D.; Fujiwara, K.; Murai, A. Synlett 2000, 1733.
74. (e) Micalizio, G. C.; Roush, W. R. Org. Lett. 2001, 3, 1949.
75. (f) Paquette, L. A.; Peng, X.; Bondar, D. Org. Lett. 2002, 4, 937.
76. (g) Bondar, D.; Liu, J.; Müller, T.; Paquette, L. A. Org. Lett. 2005, 7, 1813.
77. Jung, J. H.; Sim, C. J.; Lee, C.-O. J. Nat. Prod. 1995, 58, 1722.
78. (a) Spector, I.; Braet, F.; Schochet, N. R.; Bubb, M. R. Microscop. Res. Technol. 1999, 47, 18.
79. (b) Leira, F.; Cabadon, A. G.; Vieytes, M. R.; Roman, Y.; Alfonso, A.; Botana, L. M.; Yasumoto, T.; Malaguti, C.; Rossini, G. P. Biochem. Pharmacol. 2002, 63, 1979.
80. Yasumoto, T.; Murata, M.; Lee, J.-S.; Torigoe, K. Bioactive Molecules: Mycotoxins and Phycotoxins'88; Natori, S., Hashimoto, K., Ueno, Y., Eds.; Elsevier: New York, 1989; Vol. 10, p 375.
81. Pihko, P. M.; Aho, J. E. Org. Lett. 2004, 6, 3849.
82. Vidal, J.-P.; Escale, R.; Girard, J.-P.; Rossi, J.-C.; Chantraine, J.-M.; Aumelas, A. J. Org. Chem. 1992, 57, 5857.
83. Smith, A. B., III; Frohn, M. Org. Lett. 2001, 3, 3979.
84. DeShong, P.; Waltermire, R. E.; Ammon, H. L. J. Am. Chem. Soc. 1988, 110, 1901.
85. Tursun, A.; Canet, I.; Aboab, B.; Sinibaldi, M.-E. Tetrahedron Lett. 2005, 46, 2291.
86. Takaoka, L. R.; Buckmelter, A. J.; La Cruz, T. E.; Rychnovsky, S. D. J. Am. Chem. Soc. 2005, 127, 528.
87. La Cruz, T. E.; Rychnovsky, S. D. Org. Lett. 2005, 7, 1873.
88. (a) Kitching, W.; Lewis, J. A.; Fletcher, M. T.; De Voss, J. J.; Drew, R. A. I.; Moore, C. J. J. Chem. Soc., Chem. Commun. 1986, 855.
89. (b) Kitching, W.; Lewis, J. A.; Perkins, M. V.; Drew, R.; Moore, C. J.; Schurig, V.; König, W. A.; Francke, W. J. Org. Chem. 1989, 54, 3893.
90. (c) Perkins, M. V.; Kitching, W. J. Chem. Soc., Perkin. Trans. 1 1990, 2501.
91. (d) Perkins, M. V.; Jacobs, M. F.; Kitching, W.; Cassidy, P. J.; Lewis, J. A.; Drew, R. A. I. J. Org. Chem. 1992, 57, 3365.
92. (e) Chen, J.; Fletcher, M. T.; Kitching, W. Tetrahedron: Asymmetry 1995, 6, 967.
93. (a) Mori, K.; Tanida, K. Heterocycles 1981, 15, 1171.
94. (b) Mori, K.; Tanida, K. Tetrahedron 1981, 37, 3221.
95. (c) Mori, K.; Ikunaka, M. Tetrahedron 1984, 40, 3471.
96. (d) Mori, K.; Uematsu, T.; Watanabe, H.; Yanagi, K.; Minobe, M. Tetrahedron Lett. 1984, 25, 3875.
97. (e) Mori, K.; Watanabe, H.; Yanagi, K.; Minobe, M. Tetrahedron 1985, 41, 3663.
98. (f) Mori, K.; Watanabe, H. Tetrahedron 1986, 42, 295.
99. For examples of other studies concerning insect pheromones (anomeric), see: (a) Ley, S. V.; Lygo, B. Tetrahedron Lett. 1982, 23, 4625.
100. (b) Amouroux, R Heterocycles 1984, 22, 1489.
101. Deslongchamps, P.; Rowan, D. D.; Pothier, N.; Saunders, J. K. Can. J. Chem. 1981, 59, 1122.
102. Kay, I. T.; Williams, E. G. Tetrahedron Lett. 1983, 24, 5915.
103. Holtzel, A.; Kempter, C.; Metzger, J. W.; Jung, G.; Groyh, I.; Fritz, T.; Fiedler, H.-P. J. Antibiot. 1998, 51, 699.
104. (a) Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1409.
105. (b) Takahashi, H.; Osada, H.; Koshino, H.; Sasaki, M.; Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1414.
106. Zanatta, S. D.; White, J. M.; Rizzacasa, M. A. Org. Lett. 2004, 6, 1041.
107. Shimizu, T.; Kusaka, J.; Ishiyama, H.; Nakata, T. Tetrahedron Lett. 2003, 44, 4965.
108. Dias, L. C.; de Oliveira, L. G. Org. Lett. 2004, 6, 2587.
109. The Rychnovsky approach is a very clever example of the generality and utility of the anomeric effect. Presumably, the radical intermediate generated by the reduction of the oxonium cation derived from 109 can still undergo inversion of stereochemistry. The axial radical is preferred, apparently as a result of the anomeric effect (for discussions, see: Rychnovsky, S. D.; Powers, J. P.; LePage, T. J. J. Am. Chem. Soc. 1992, 114, 8375)
110. see below. When the second electron is added in the reduction, the resulting anion can no longer undergo inversion and therefore remains locked in the axial configuration! The configurational stability of a-oxygenated alkyllithiums is well documented: Still, W. C.; Sreekumar, C. J. Am. Chem. Soc. 1980, 102, 1201.
111. (a) Pettit, G. R.; Cichacz, Z. A.; Gao, F.; Herald, C. L.; Boyd, M. R.; Schmidt, J. M.; Hooper, J. N. A. J. Org. Chem. 1993, 58, 1302.
112. (b) Pettit, G. R.; Cichacz, Z. A.; Gao, F.; Herald, C. L.; Boyd, M. R. J. Chem. Soc., Chem. Commun. 1993, 1166.
113. (c) Pettit, G. R.; Herald, C. L.; Cichacz, Z. A.; Gao, F.; Schmidt, J. M.; Boyd, M. R.; Christie, N. D.; Boettner, F. E. J. Chem. Soc., Chem. Commun. 1993, 1805.
114. (d) Pettit, G. R.; Herald, C. L.; Cichacz, Z. A.; Gao, F.; Boyd, M. R.; Christie, N. D.; Schmidt, J. M. Nat. Prod. Lett. 1993, 3, 239.
115. (e) Pettit, G. R.; Cichacz, Z. A.; Herald, C. L.; Gao, F.; Boyd, M. R.; Schmidt, J. M.; Hamel, E.; Bai, R. J. Chem. Soc., Chem. Commun. 1994, 1605.
116. Fusetani, N.; Shinoda, K.; Matsunaga, S. J. Am. Chem. Soc. 1993, 115, 3977.
117. (a) Kobayashi, M.; Aoki, S.; Sakai, H.; Kawazoe, K.; Kihara, N.; Sasaki, T.; Kitagawa, I. Tetrahedron Lett. 1993, 34, 2795.
118. (b) Kobayashi, M.; Aoki, S.; Sakai, H.; Kihara, N.; Sasaki, T.; Kitagawa, I. Chem. Pharm. Bull. 1993, 41, 989.
119. (a) Kobayashi, M.; Aoki, S.; Kitagawa, I. Tetrahedron Lett. 1994, 35, 1243.
120. (b) Kobayashi, M.; Aoki, S.; Gato, K.; Kitagawa, I. Chem. Pharm. Bull. 1996, 44, 2142.
121. (a) Evans, D. A.; Coleman, P. J.; Diaz, L. C. Angew. Chem., Int. Ed. Engl. 1997, 36, 2737.
122. (b) Evans, D. A.; Trotter, B. W.; Côté, B.; Coleman, P. J.Angew. Chem., Int. Ed. Engl. 1997, 36, 2741.
123. (c) Evans, D. A.; Trotter, B. W.; Côté, B.; Coleman, P. J.; Dias, L. C.; Tyler, A. N. Angew. Chem., Int. Ed. Engl. 1997, 36, 2744.
124. (a) Guo, J.; Duffy, K. J.; Stevens, K. L.; Dalko, P. I.; Roth, R. M.; Hayward, M. M.; Kishi, Y. Angew. Chem., Int. Ed. Engl. 1998, 37, 187.
125. (b) Hayward, M. M.; Roth, R. M.; Duffy, K. J.; Dalko, P. I.; Stevens, K. L.; Guo, J.; Kishi, Y. Angew. Chem., Int. Ed. Engl. 1998, 37, 190.
126. See ref 53a
127. and (a) Evans, D. A.; Trotter, B. W.; Coleman, P. J.; Côtè, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, A. N. Tetrahedron 1999, 55, 8671.
128. Paquette, L. A.; Braun, A. Tetrahedron Lett. 1997, 38, 5119.
129. (a) Smith A. B., III; Doughty, V. A.; Lin, Q.; Zhuang, L.; McIlriar, M. D.; Boldi, A. M.; Moser, W. H.; Murase, N.; Nakayama, K.; Sobukawa, M. Angew. Chem., Int. Ed. 2001, 40, 191.
130. (b) Smith, A. B., III; Lin, Q.; Doughty, V. A.; Zhuang, L.; McBriar, M. D.; Kerns, J. K.; Brook, C. S.; Murase, N.; Nakayama, K. Angew. Chem., Int. Ed. 2001, 40, 196.
131. 2+-Controlled spirocyclizations, see:
132. (d) Smith, A. B., III; Zhuang, L.; Brook, C. S.; Lin, Q.; Moser, W. H.; Trout, R. E. L.; Boldi, A. M. Tetrahedron Lett. 1997, 38, 8671.
133. Paterson, I.; Chen, D. Y.-K.; Coster, M. J.; Aceña, J. L.; Bach, J.; Gibson, K. R.; Keown, L. E.; Oballa, R. M.; Trieselmann, T.; Wallace, D. J.; Norcross, R. D. Angew. Chem., Int. Ed. 2001, 40, 4055.
134. (a) Paterson, I.; Wallace, D. J.; Gibson, K. R. Tetrahedron Lett. 1997, 38, 8911. For a more recent and a slightly modified CD spiroketal synthesis, see:
135. (b) Paterson, I.; Coster, M. J. Tetrahedron Lett. 2002, 43, 3285.
136. Negri, D. P.; Kishi, Y. Tetrahedron Lett. 1987, 28, 1063.
137. Hayes, C. J.; Heathcock, C. H. J. Org Chem. 1997, 62, 2678.
138. Zemribo, R.; Mead, K. T. Tetrahedron Lett. 1998, 39, 3891.
139. Zemribo, R.; Mead, K. T. Tetrahedron Lett. 1998, 39, 3895.
140. (a) Heathcock, C. H.; McLaughlin, M.; Medina, J.; Hubbs, J. L.; Wallace, G. A.; Scott, R.; Claffey, M. M.; Hayes, C. J.; Ott, G. R. J. Am. Chem. Soc. 2003, 125, 12844.
141. (b) Wallace, G. A.; Scott, R.; Heathcock, C. H. J. Org. Chem. 2000, 65, 4145.
142. (c) Ott, G. R.; Heathcock, C. H. Org. Lett. 1999, 1, 1475.
143. (d) Claffey, M. M.; Heathcock, C. H. J. Org. Chem. 1996, 61, 7646.
144. (a) Claffey, M. M.; Hayes, C. J.; Heathcock, C. H. J. Org. Chem. 1999, 64, 8267.
145. (b) Hubbs, J. L.; Heathcock, C. H. J. Am. Chem. Soc. 2003, 125, 12836.
146. Romero, J. A. C.; Tabacco, S. A.; Woerpel, K. A. J. Am. Chem. Soc. 2000, 122, 168.
147. (a) Terauchi, T.; Sato, I.; Tsukada, T.; Kanoh, N.; Nakata, M. Tetrahedron Lett. 2000, 41, 2649. For the formal total synthesis of spongistatin 2, see:
148. (b) Terauchi, T.; Terauchi, T.; Sato, I.; Shoji, W.; Tsukada, T.; Tsunoda, T.; Kanoh, N.; Nakata, M. Tetrahedron Lett. 2003, 44, 7741.
149. (c) Terauchi, T.; Tanaka, T.; Terauchi, T.; Morita, M.; Kimijima, K.; Sato, I.; Shoji, W.; Nakamura, Y.; Tsukada, T.; Tsunoda, T.; Hayashi, G.; Kanoh, N.; Nakata, M. Tetrahedron Lett. 2003, 44, 7747.
150. For the synthesis of the CD spiroketal, see: (a) Crimmins, M. T.; Katz, J. D. Org. Lett. 2000, 2, 957. For the total synthesis, see:. For the total synthesis, see:
151. (b) Crimmins, M. T.; Katz, J. D.; Washburn, D. G.; Allwein, S. P.; McAtee, L. F. J. Am. Chem. Soc. 2002, 124, 5661.
152. Jacobs, M. F.; Glenn, M. P.; McGrath, M. J.; Zhang, H.; Brereton, I.; Kitching, W. Arkivoc General Papers, 2001, ms. 114-137.
153. Holson, E. B.; Roush, W. R. Org. Lett. 2002, 4, 3719.
154. Gaunt, M. J.; Hook, D. F.; Tanner, H. R.; Ley, S. V. Org. Lett. 2003, 5, 4815.
155. (a) Ball, M.; Gaunt, M. J.; Hook, D. F.; Jessiman, A. S.; Kawahara, S.; Orsini, P.; Scolaro, A.; Talbot, A. C.; Tanner, H. R.; Yamanoi, S.; Ley, S. V. Angew. Chem., Int. Ed. 2005, 44, 5433.
156. (b) Kawahara, S.; Gaunt, M. J.; Scolaro, A.; Yamanoi, S.; Ley, S. V. Synlett 2005, 2031.
157. Lau, C. K.; Crumpler, S.; Macfarlane, K.; Lee, F.; Berthelette, C. Synlett 2004, 2281.
158. (a) Kato, Y.; Scheuer, P. J. J. Am. Chem. Soc. 1974, 96, 2245.
159. (b) Kato, Y.; Scheuer, P. J. Pure Appl. Chem. 1975, 41, 1.
160. (c) Kato, Y.; Scheuer, P. J. Pure Appl. Chem. 1976, 48, 29.
161. (a) Mynderse, J. S.; Moore, R. E. J. Org. Chem. 1978, 43, 2301.
162. (b) Moore, R. E. Pure Appl. Chem. 1982, 54, 1919.
163. (c) Moore, R. E.; Blackman, A. J.; Cheuk, C. E.; Mynderse, J. S.; Matsumoto, G. K.; Clardy, J.; Wooward, R. W.; Craig, J. C. J. Org. Chem. 1984, 49, 2484.
164. (d) Entzeroth, M.; Blackman, A. J.; Mynderse, J. S.; Moore, R. E. J. Org. Chem. 1985, 50, 1255.
165. Park, P.-U.; Broka, C. A.; Johnson, B. F.; Kishi, Y. J. Am. Chem. Soc. 1987, 109, 6205.
166. Masamune, S.; Bates, G. S.; Corcoran, J. W. Angew. Chem., Int. Ed. Engl. 1977, 16, 585.
167. Ireland, R. E.; Thaisrivongs, S.; Dussault, P. H. J. Am. Chem. Soc. 1988, 110, 5768.
168. For precise discussion and further information, see refs 78
169. and 3b.
170. Toshima, H.; Suzuki, T.; Nishiyama, S.; Yamamura, S. Tetrahedron Lett. 1989, 30, 6725.
171. (a) Osada, H.; Koshino, H.; Isono, K.; Takahashi, H.; Kawanishi, G. J. Antibiot. 1991, 44, 259.
172. (b) Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1409.
173. (c) Takahashi, H.; Osada, H.; Koshino, H.; Sasaki, M.; Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1414.
174. (d) Koshino, H.; Takahashi, H.; Osada, H.; Isono, K. J. Antibiot. 1992, 45, 1420.
175. Shimizu, T.; Masuda, T.; Hiramoto, K.; Nakata, T. Org. Lett. 2000, 2, 2153.
176. Drouet, K. E.; Ling, T.; Tran, H. V.; Theodorakis, E. A. Org. Lett. 2000, 2, 207.
177. Williams, D. R.; Barner, B. A. Tetrahedron Lett. 1983, 24, 427.
178. Kocienski, P.; Street, S. D. A. J. Chem. Soc., Chem. Commun. 1984, 571.
179. (a) Ireland, R. E.; Daub, J. P. J. Org. Chem. 1983, 48, 1303.
180. (b) Ireland, R. E.; Daub, J. P. J. Org. Chem. 1983, 48, 1312.
181. Tietze, L. F.; Schneider, C. J. Org. Chem. 1991, 56, 2476.
182. For reviews on the chemistry and synthesis of tricyclic spiroketal systems, see: (a) Brimble, M. A.; Fares, F. A. Tetrahedron 1999, 55, 7661.
183. (b) Brimble, M. A.; Furkert, D. P. Curr. Org. Chem. 2003, 7, 1461.
184. For studies on dispiroketals, see: (a) Brimble, M. A.; Rush, C. J. J. Chem. Soc., Perkin Trans. 1 1994, 497.
185. (b) McGarvey, G. J.; Stepanian, M. W.; Bressette, A. R.; Ellena, J. F. Tetrahedron Lett. 1996, 37, 5461.
186. (c) McGarvey, G. J.; Stepanian, M. W.; Bressette, A. R.; Ellena, J. F. Tetrahedron Lett. 1996, 37, 5465.
187. Faul, M. M.; Huff, B. E. Chem. Rev. 2000, 100, 2407.
188. (a) Miyazaki, Y.; Shibuya, M.; Sugawara, H.; Kawaguchi, O.; Hirose, C.; Nagatsu, J. J. Antibiot. 1974, 27, 814.
189. (b) Kinashi, H.; Ôtake, N.; Yonehara, H.; Sato, S.; Saito, Y. Tetrahedron Lett. 1973, 4955.
190. (c) Kinashi, H.; Ôtake, N.; Yonehara, H.; Sato, S.; Saito, Y. Acta Crystallogr. 1975, 31, 2411.
191. (a) Westley, J. W.; Blount, J. F.; Evans, R. H.; Liu, C. J. Antibiot. 1977, 30, 610.
192. (b) Berg, D. H.; Hamill, R. L. J. Antibiot. 1978, 38, 1.
193. (c) Occolowitz, J. L.; Berg, D. H.; DeBuno, M.; Hamill, R. L. Biomed. Mass Spectrom. 1976, 3, 272.
194. (d) Seto, H.; Yahagi, T.; Miyazaki, Y.; Ôtake, N. J. Antibiot. 1977, 30, 530.
195. (e) Keller-Juslen, C.; King, H. D.; Kuhn, M.; Loosli, H.; Von Wartburg, A. J. Antibiot. 1978, 31, 820.
196. (f) Westley, J. W.; Evans, R. H.; Sello, L. H.; Troupe, N.; Liu, C.; Blount, J. F.; Pitcher, R. G.; Williams, T. H.; Miller, P. A. J. Antibiot. 1981, 34, 139.
197. For a comprehensive review on the chemistry and biology of polyether antibiotics including salinomycin, see: Westley, J. W. Polyether Antibiotics; Marcel Dekker: New York, 1983.
198. See ref 3b
199. and 8b and references therein.
200. See ref 91b, c and (a) Kishi, Y.; Hatakeyama, S.; Lewis, M. D. Total synthesis of narasin and salinomycin. In Frontiers of Chemistry; Pergamon Press: Oxford, 1982; p 287.
201. (b) Mronga, S.; Muller, G.; Fischer, J.; Ridell, F. J. Am. Chem. Soc. 1993, 115, 8414.
202. (a) Horita, K.; Nakato, S.; Oikawa, Y.; Yonemitsu, O. Tetrahedron Lett. 1987, 288, 3253.
203. (b) Horita, K.; Oikawa, Y.; Nakato, S.; Yonemitsu, O. Tetrahedron Lett. 1988, 29, 5143.
204. (c) Horita, K.; Oikawa, Y.; Yonemitsu, O. Chem. Pharm. Bull. 1989, 37, 1698.
205. (d) Horita, K.; Nagato, S.; Oikawa, Y.; Yonemitsu, O. Chem. Pharm. Bull. 1989, 37, 1705.
206. (e) Horita, K.; Oikawa, Y.; Nagato, S.; Yonemitsu, O. Chem. Pharm. Bull. 1989, 37, 1717.
207. (f) Horita, K.; Nagato, S.; Oikawa, Y.; Yonemitsu, O. Chem. Pharm. Bull. 1989, 37, 1726.
208. See ref 96
209. and (a) Horita, K.; Oikawa, Y.; Nakato, S.; Yonemitsu, O. Tetrahedron Lett. 1988, 29, 5143.
210. (a) Brown, R. C. D.; Kocienski, P. J. Synlett 1994, 415.
211. (b) Brown, R. C. D.; Kocienski, P. J. Synlett 1994, 417.
212. (c) Kocienski, P. J.; Brown, R. C. D. J. Chem. Soc., Perkin Trans. 1998, 1, 9.
213. For earlier studies on oxidative rearrangements in spiroketal synthesis, see: Kocienski, P.; Fall, Y.; Whitby, R. J. Chem. Soc., Perkin Trans. 1 1989, 841.
214. (a) Baker, R.; Brimble, M. A. J. Chem. Soc., Chem. Commun. 1985, 78.
215. (b) Baker, R.; Brimble, M. A.; Robinson, J. A. Tetrahedron Lett. 1985, 26, 2115.
216. (c) Baker, R.; Brimble, M. A. J. Chem. Soc., Perkin Trans. 1 1988, 125.
217. (d) Brimble, M. A.; Williams, G. M.; Baker, R. J. Chem. Soc., Perkin Trans. 1 1991, 2221.
218. (e) Brimble, M. A.; Williams, G. M. J. Org. Chem. 1992, 57, 5818.
219. (f) Allen, P. R.; Brimble, M. A.; Fares, F. A. J. Chem. Soc., Perkin Trans. 1 1998, 2403.
220. (g) Brimble, M. A.; Fares, F. A.; Turner, P. J. Chem. Soc., Perkin Trans. 1 1998, 677.
221. (h) Brimble, M. A. J. Heterocycl. Chem. 1999, 36, 1373.
222. (i) Allen, P. R.; Brimble, M. A.; Prabaharan, H. Synlett 1999, 295.
223. (j) Allen, P. R.; Brimble, M. A.; Prabaharan, H. J. Chem. Soc., Perkin Trans. 1 2001, 379.
224. (k) Brimble, M. A. Molecules 2004, 9, 394.
225. (a) Kalvoda, J.; Heusler, K. Synthesis 1971, 501.
226. (b) Francisco, C. G.; Freire, R.; Hernández, R.; Medina, M. C.; Suárez, E. Tetrahedron Lett. 1983, 24, 4621.
227. (c) Concepción, J. I.; Francisco, C. G.; Hernández, R.; Salazar, J. A.; Suárez, E. Tetrahedron Lett. 1984, 25, 1953.
228. (d) Majetich, G.; Wheless, K. Tetrahedron 1995, 51, 7095.
229. Perron, F.; Albizati, K. F. J. Org. Chem. 1989, 54, 2044.
230. Uemura, D.; Chou, T.; Haino, T.; Nagatsu, A.; Fukuzawa, S.; Zheng, S. Z.; Chen, H. S. J. Am. Chem. Soc. 1995, 117, 1155.
231. McCauley, J. A.; Nagasawa, K.; Lander, P. A.; Mischke, S. G.; Semones, M. A.; Kishi, Y. J. Am. Chem. Soc. 1998, 120, 7647.
232. For the formal total synthesis, see: (a) Sakamoto, S.; Sakazaki, H.; Hagiwara, K.; Kamada, K.; Ishii, K.; Noda, T.; Inoue, M.; Hirama, M. Angew. Chem., Int. Ed. 2004, 43, 6505.
233. For the synthesis of the BCD dispiroketal moiety see: (b) Noda, T.; Ishiwata, A.; Uemura, S.; Sakamoto, S.; Hirama, M. Synlett 1998, 298.
234. For other synthetic studies of pinnatoxin A, see: (c) Ishiwata, A.; Sakamoto, S.; Noda, T.; Hirama, M. Synlett 1999, 692.
235. (d) Nitta, A.; Ishiwata, A.; Noda, T.; Hirama, M. Synlett 1999, 695.
236. (e) Wang, J.; Sakamoto, S.; Kamada, K.; Nitta, A.; Noda, T.; Oguri, H.; Hirama, M. Synlett 2003, 891.
237. (a) Sugimoto, T.; Ishihara, J.; Murai, A. Tetrahedron Lett. 1997, 38, 7379.
238. (b) Sugimoto, T.; Ishihara, J.; Murai, A. Synlett 1999, 541.
239. (c) Ishihara, J.; Tojo, S.; Kamikawa, A.; Murai, A. Chem. Commun. 2001, 1392.
240. Ishihara, J.; Sugimoto, T.; Murai, A. Synlett 1998, 603.
241. This result underscores the difficulties associated with computational modeling of structures stabilized by hydrogen bonding. For further discussion, see: Gilli, G.; Gilli, P. J. Mol. Struct. 2000, 552, 1.
242. (a) Nakamura, S.; Inagaki, J.; Sugimoto, T.; Kudo, M.; Nakajima, M.; Hashimoto, S. Org. Lett. 2001, 3, 4075. For detailed consideration of the stereochemical models, see:
243. (b) Nakamura, S.; Inagaki, J.; Kudo, M.; Sugimoto, T.; Obara, K.; Nakajima, M.; Hashimoto, S. Tetrahedron 2002, 58, 10353.
244. Satake, M.; Ofuji, K.; Naoki, H.; James, K. J.; Furey, A.; McMahon, T.; Silke, J.; Yasumoto, T. J. Am. Chem. Soc. 1998, 120, 9967.
245. (a) Ofuji, K.; Satake, M.; McMahon, T.; Silke, J.; James, K. J.; Naoki, H.; Oshima, Y.; Yasumoto, T. Nat. Toxins 1999, 7, 99.
246. (b) Ofuji, K.; Satake, M.; McMahon, T.; James, K. J.; Naoki, H.; Oshima, Y.; Yasumoto, T. Biosci. Biotechnol. Biochem. 2001, 65, 740.
247. McMahon, T.; Silke, J. Harmful Algae News 1996, 14, 2.
248. (a) Nicolaou, K. C.; Vyskocil, S.; Koftis, T. V.; Yamada, Y. M. A.; Ling, T.; Chen, D. Y.-K.; Tang, W.; Petrovic, G.; Frederick, M. O.; Satake, Y. M. Angew. Chem., Int. Ed. 2004, 43, 4312.
249. (b) Nicolaou, K. C.; Koftis, T. V.; Vyskocil, S.; Petrovic, G.; Ling, T.; Yamada, Y. M. A.; Tang, W.; Frederick, M. O. Angew. Chem., Int. Ed. 2004, 43, 4318. For other publications covering the structural revision, see:
250. (c) Nicolaou, K. C.; Li, Y.; Uesaka, N.; Koftis, T. V.; Vyskocil, S.; Ling, T.; Govindasamy, M.; Qian, W.; Bernal, F.; Chen, D. Y.-K. Angew. Chem., Int. Ed. 2003, 42, 3643.
251. (d) Nicolaou, K. C.; Chen, D. Y.-K.; Li, Y.; Qian, W.; Ling, T.; Vyskocil, S.; Koftis, T. V.; Govindasamy, M.; Uesaka, N.
252. (e) Nicolaou, K. C.; Snyder, S. A. Angew. Chem., Int. Ed. 2005, 44, 1012.
253. Nicolaou, K. C.; Qian, W.; Bernal, F.; Uesaka, N.; Pihko, P. M.; Hinrichs, J. Angew. Chem., Int. Ed. 2001, 40, 4068.
254. (a) Carter, R. G.; Graves, D. E. Tetrahedron Lett. 2001, 42, 6035.
255. (b) Carter, R. C.; Bourland, T. C.; Graves, D. E. Org. Lett. 2002, 4, 2177.
256. (c) Carter, R. G.; Graves, D. E.; Gronemeyer, M. A.; Tschumper, G. S. Org. Lett. 2002, 4, 2181.
257. (d) Carter, R. G.; Bourland, T. C.; Zhou, X.-T.; Gronemeyer, M. A. Tetrahedron 2003, 59, 8963.
258. (e) Zhou, X.-T.; Carter, R. G. Chem. Commun. 2004, 2138.
259. (a) Ishikawa, Y.; Nishiyama, S. Tetrahedron Lett. 2004, 45, 351.
260. (b) Ishikawa, Y.; Nishiyama, S. Heterocycles 2004, 63, 539.
261. (c) Ishikawa, Y.; Nishiyama, S. Heterocycles 2004, 63, 885.
262. Potuzak, J. S.; Moilanen, S. B.; Tan, D. S. J. Am. Chem. Soc. 2005, 127, 13796.